Skip to main content

Advertisement

SpringerLink
Log in

Serum Lipid Profile: Fasting or Non-fasting?

  • Letter to the editor
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Serum lipid profile has now become almost a routine test. It is usually done in fasting state due to certain limitations in non-fasting serum sample. In the recent past efforts have been made to simplify blood sampling by replacing fasting lipid profile with non-fasting lipid profile. However, fasting specimen is preferred if cardiovascular risk assessment is based on total cholesterol, LDL cholesterol or non-HDL cholesterol. A lot has yet to be done in this area. Till then we have to believe in fasting lipid profile for assessment and management of cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Campose H, Khoo C, Sacks FM. Diurnal and acute pattern of postprandial apolipoprotein B-48 in VLDL, IDL and LDL from normolipidemic human. Atherosclerosis. 2005;181:345–51.

    Article  Google Scholar 

  2. Third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106:3143–3421.

    Google Scholar 

  3. De Backer G, Ambrosioni E, Borch-Johnson K, Brotons C, et al. European guidelines on cardiovascular disease and prevention in clinical practice. Atherosclerosis. 2003;171:145–55.

    Article  PubMed  Google Scholar 

  4. Sahu S, Chawla R, Uppal B. Comparison of two methods of estimation of low density lipoprotein cholesterol, the direct versus Friedewald estimation. Indian J Clin Biochem. 2005;20:54–61.

    Article  CAS  Google Scholar 

  5. Mora S, Rifai N, Buring JE, Ridker PM. Comparison of LDL cholesterol concentration by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women. Clin Chem. 2009;55:888–94.

    Article  CAS  PubMed  Google Scholar 

  6. Nordestgaard BG, Langsted A, Freiberg JJ. Nonfasting hyperlipidemia and cardiovascular disease. Curr Drug Targets. 2009;10:54–61.

    Article  Google Scholar 

  7. Mora S, Rifai N, Burring JE, Ridker PM. Fasting compared with nonfasting lipids and Apolipoproeins for predicting incident cardiovascular events. Circulation. 2008;118:993–1001.

    Article  CAS  PubMed  Google Scholar 

  8. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298:309–16.

    Article  CAS  PubMed  Google Scholar 

  9. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease and death in men and women. JAMA. 2007;298:299–308.

    Article  CAS  PubMed  Google Scholar 

  10. Ridker PM. Fasting versus nonfasting triglycerides and prediction of cardiovascular risk: do we need to revisit the oral triglyceride tolerance test? Clin Chem. 2008;54:11–3.

    Article  CAS  PubMed  Google Scholar 

  11. Narayana S. Pre and post analytical errors in lipid determination. Indian J Clin Biochem. 1996;11:12–6.

    Article  Google Scholar 

  12. Young DS. Biological variability. In: Brown SS, Mitchell FL, Young DS, editors. Chemical Diagnosis of Disease. New York: Elsevier; 1979. p. 1–113.

    Google Scholar 

  13. Cooper GR, Myers GL, Smith J, Schlant RC. Blood lipid measurements: variations and practical utility. JAMA. 1992;267:1652–60.

    Article  CAS  PubMed  Google Scholar 

  14. Narayanan S. Physiological variables in blood sampling. Mitt Klin Chem. 1993;24:130–4.

    Google Scholar 

  15. Joven J, Villabona C, Vilella E. Abnormalities of lipoprotein metabolism in patients with nephrotic syndrome. N Engl J Med. 1990;323:579–84.

    Article  CAS  PubMed  Google Scholar 

  16. Alvarez C, Ramos A. Lipids, lipoproteins and apolipoproteins in serum during infection. Clin Chem. 1986;32:142–5.

    CAS  PubMed  Google Scholar 

  17. Ryder REJ, Hayes TM, Mulligan JP, Kingswood JC, Williams S, Owens DR. How soon after myocardial infarction should plasma lipid values be assessed? Br Med J. 1984;289:1651–3.

    Article  CAS  Google Scholar 

  18. Nigam PK, Narain VS, Hasan M. Serum lipid profile in patients with acute myocardial infarction. Indian J Clin Biochem. 2004;19:67–70.

    Article  CAS  Google Scholar 

  19. Nawaz H, Comerford BP, Njike VY, Dhond AJ, Plavec M, Katz DL. Repeated serum lipid measurements during the perihospitalization period. Am J Cardiol. 2006;98:1379–82.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, CSM Medical University, U.P., Lucknow, 226003, India

    P. K. Nigam

Authors
  1. P. K. Nigam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. K. Nigam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nigam, P.K. Serum Lipid Profile: Fasting or Non-fasting?. Ind J Clin Biochem 26, 96–97 (2011). https://doi.org/10.1007/s12291-010-0095-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-010-0095-x

Keywords

Search

Navigation